CD14 and colorectal carcinoma: By comparison of all CRC patients and healthy donors, matched by age and gender, no statistically significant differences were identified between the percentage of major monocyte subpopulations: classical (CD14+CD16-), intermediate (CD14+CD16+) and non-classical (CD14-CD16+) (Table 1).